Srinagar: The Jammu and Kashmir on Monday recorded the death of six more people due to the novel Coronavirus, taking the overall toll to 324 in the erstwhile state.
Six patients who tested positive and subsequently died include a 65-year-old from Safakadal Srinagar, a 65-year-old from Hanjoora village of Chadoora district Budgam, an a-60-year-old man from Hawal Srinagar, a 60-year old man from Bemina Srinagar, a 70-year-old man from Behipora village of south Kashmir’s Kulgam district and a 60-year-old man from Buchpora, Srinagar.
Earlier a day ago, officials said that out of 17920 positive cases, 7,680 are Active Positive, 9,928 have recovered and 312 have died; 23 in Jammu division and 289 in Kashmir.
Officials added that out of 5,81,707 test results available, 5,63,787 samples have been tested as negative till July 26, 2020.
Additionally, till date, 3,54,869 travellers and persons in contact with suspected cases have been enlisted for observation which included 44,429 persons in home quarantine including facilities operated by government, 12 in Hospital Quarantine, 7,680 in hospital isolation and 40180 under home surveillance.
A statement from the JK administration said that of the total 17920 positive cases in JK 3,977 have been reported as travellers while 13,943 as others.
In India, as the COVID infections continue to mount as the country’s total case tally has crossed the 14 lakh mark.
According to the Health Ministry of India, fresh 49,931 COVID cases were reported in 24 hours, taking the total tally to 14.3 lakh.
As per the data, more than 9.1 lakh patients have recovered so far.
At present, there are 14,35,453 confirmed cases, 4,85,114 active cases, and 9,17,568 patients have been discharged, cured.
A day ago, India reported 48,916 new cases during the last 24 hours, taking the total number of cases to 13,36,861, the government data shows.
The country also witnessed 757 virus-related deaths during the period, according to the data released by the Health Ministry.
With 33,461 deaths, the fatality count in India is now the third-biggest in the world; the country is behind the US and Brazil.
Earlier on July 25, a week after the All India Institute of Medical Sciences (AIIMS) gave its approval for conducting the human clinical trial of the COVID vaccine, a 30-year-old man was given the first dose of under trial vaccine Covaxin.
A total of 12 volunteers were called for a number of pre-tests that include blood and nasopharyngeal testing for the deadly coronavirus.
Soon after the results were found, 10 healthy individuals were selected for the vaccine to be given in phases, reports said adding, a report on their health condition will be submitted to the ethics committee, which will reviewing the entire process.
In wake of the COVID outbreak, recent research published by United Nations International Children’s Emergency Fund (UNICEF), said that at least 40 million children worldwide have missed out on early childhood education in their critical pre-school year due to the COVID closing the childcare and early education facilities.
Earlier on July 21, Council of Scientific and Industrial Research (CSIR) chief Shekhar C Mande asserted that airborne transmission of COVID is indeed a “distinct possibility” and advised people to wear masks even in enclosed spaces.
Free Press Kashmir is now on Telegram. Click here to Join.